Vident Advisory LLC Sells 602 Shares of Chemed Corporation $CHE

Key Points

• Vident Advisory LLC has reduced its position in Chemed Corporation (NYSE: CHE) by 44.9% in the first quarter, now holding 738 shares worth approximately $454,000.
• Chemed's stock has had a volatile performance, with a market capitalization of $6.79 billion and a current price around $465.72, significantly down from its fifty-two week high of $623.60.
• The company recently announced an increase in its quarterly dividend, now at $0.60 per share, up from $0.50, reflecting continued financial stability despite challenges.

Vident Advisory LLC lowered its position in shares of Chemed Corporation (NYSE:CHE - Free Report) by 44.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 738 shares of the company's stock after selling 602 shares during the quarter. Vident Advisory LLC's holdings in Chemed were worth $454,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Alpine Bank Wealth Management purchased a new stake in shares of Chemed in the first quarter valued at $29,000. HM Payson & Co. purchased a new stake in shares of Chemed in the first quarter valued at $30,000. SVB Wealth LLC purchased a new stake in shares of Chemed in the first quarter valued at $30,000. Whipplewood Advisors LLC lifted its holdings in shares of Chemed by 54.5% in the first quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock valued at $31,000 after purchasing an additional 18 shares in the last quarter. Finally, WPG Advisers LLC purchased a new stake in shares of Chemed in the first quarter valued at $32,000. Institutional investors and hedge funds own 95.85% of the company's stock.

Insider Transactions at Chemed

In other news, Director Patrick P. Grace sold 150 shares of Chemed stock in a transaction dated Tuesday, September 9th. The stock was sold at an average price of $463.39, for a total value of $69,508.50. Following the transaction, the director directly owned 3,397 shares in the company, valued at approximately $1,574,135.83. The trade was a 4.23% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director George J. Walsh III bought 200 shares of the business's stock in a transaction that occurred on Monday, August 4th. The shares were bought at an average price of $417.10 per share, with a total value of $83,420.00. Following the completion of the purchase, the director owned 3,523 shares in the company, valued at approximately $1,469,443.30. The trade was a 6.02% increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.29% of the stock is currently owned by corporate insiders.

Chemed Trading Up 1.0%

NYSE CHE traded up $4.71 during trading on Thursday, hitting $455.41. 85,053 shares of the company traded hands, compared to its average volume of 141,387. Chemed Corporation has a 12 month low of $408.42 and a 12 month high of $623.60. The business has a fifty day simple moving average of $452.65 and a 200 day simple moving average of $532.39. The company has a market capitalization of $6.64 billion, a P/E ratio of 23.42, a PEG ratio of 2.55 and a beta of 0.46.

Chemed (NYSE:CHE - Get Free Report) last posted its earnings results on Tuesday, July 29th. The company reported $4.27 earnings per share for the quarter, missing the consensus estimate of $6.02 by ($1.75). Chemed had a net margin of 11.56% and a return on equity of 25.83%. The company had revenue of $618.80 million for the quarter, compared to the consensus estimate of $650.60 million. During the same quarter last year, the business earned $5.47 earnings per share. Chemed's quarterly revenue was up 3.8% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Equities research analysts predict that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 11th were paid a $0.60 dividend. The ex-dividend date was Monday, August 11th. This is a boost from Chemed's previous quarterly dividend of $0.50. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. Chemed's dividend payout ratio is presently 12.34%.

Analyst Upgrades and Downgrades

CHE has been the subject of a number of research analyst reports. Royal Bank Of Canada reduced their target price on Chemed from $640.00 to $589.00 and set an "outperform" rating for the company in a report on Thursday, July 31st. Wall Street Zen lowered Chemed from a "buy" rating to a "hold" rating in a report on Saturday, July 5th. Oppenheimer cut their price objective on Chemed from $650.00 to $580.00 and set an "outperform" rating for the company in a report on Thursday, July 31st. Bank of America cut their price objective on Chemed from $610.00 to $595.00 and set a "buy" rating for the company in a report on Wednesday. Finally, Jefferies Financial Group upgraded Chemed from a "hold" rating to a "buy" rating and increased their price objective for the stock from $490.00 to $550.00 in a report on Tuesday, September 2nd. Four investment analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $578.50.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.